dc.contributor.author |
Fehér Ágnes |
|
dc.contributor.author |
Tóth Viktória |
|
dc.contributor.author |
Al-Khrasani, Mahmoud |
|
dc.contributor.author |
Balogh Mihály |
|
dc.contributor.author |
Lázár Bernadette |
|
dc.contributor.author |
Helyes Zsuzsanna |
|
dc.contributor.author |
Gyires Klára |
|
dc.contributor.author |
Zádori Zoltán Sándor |
|
dc.date.accessioned |
2017-06-27T09:13:08Z |
|
dc.date.available |
2017-06-27T09:13:08Z |
|
dc.date.issued |
2017 |
|
dc.identifier.citation |
pagination=107-118;
journalVolume=25;
journalIssueNumber=1;
journalTitle=INFLAMMOPHARMACOLOGY; |
|
dc.identifier.uri |
http://repo.lib.semmelweis.hu//handle/123456789/4086 |
|
dc.identifier.uri |
doi:10.1007/s10787-016-0299-7 |
|
dc.relation.ispartof |
urn:issn:0925-4692 |
|
dc.title |
Analysing the effect of I1 imidazoline receptor ligands on DSS-induced acute colitis in mice |
|
dc.type |
Journal Article |
|
dc.date.updated |
2017-02-13T12:44:35Z |
|
dc.language.rfc3066 |
en |
|
dc.identifier.mtmt |
3137778 |
|
dc.identifier.pubmed |
27873165 |
|
dc.contributor.department |
PTE/ÁOK/Farmakológiai és Farmakoterápiai Intézet |
|
dc.contributor.department |
SE/AOK/I/Farmakológiai és Farmakoterápiás Intézet |
|
dc.contributor.institution |
Pécsi Tudományegyetem |
|
dc.contributor.institution |
Semmelweis Egyetem |
|